Supplements
KPV MAX
2 capsules per serving
KPV MAX is a finished dietary supplement delivering the anti-inflammatory tripeptide KPV (Lys-Pro-Val) alongside palmitoylethanolamide (PEA), sodium bicarbonate, and hyaluronic acid. Each 2-capsule serving provides a targeted four-ingredient complex, with 60 capsules (30 servings) per bottle.
Amino acid sequence
Lys-Pro-Val
3 residues
$89.99
Technical notes
Research Profile
Supplement Facts per 2 capsules: KPV (tripeptide) 500 mcg; Palmitoylethanolamide (PEA) 500 mg; Sodium Bicarbonate 400 mg; Hyaluronic Acid 100 mg. Servings per container: 30. Daily values not established.
KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (α-MSH), studied in the literature for gut-barrier integrity, mucosal health, and modulation of NF-κB–driven inflammatory signaling. Palmitoylethanolamide is an endogenous fatty-acid amide researched for mast-cell modulation and comfort support.
Sodium bicarbonate buffers the capsule environment for peptide stability, and hyaluronic acid complements the formula with connective-tissue and mucosal hydration support.
Suggested use: take 2 capsules daily with water or as recommended by a healthcare professional. Do not exceed the recommended dose. Consult a physician before use if pregnant, nursing, under 18, taking medication, or managing a medical condition.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Handling & reconstitution
No reconstitution needed. Take 2 capsules daily with water or as recommended by a healthcare professional.
Lab assistant
AI Dosing & Reconstitution Assistant
Enter your vial, diluent, and target aliquot in any unit — mcg, mg, g, mL, µL, or U-100 syringe units. Every value is range-checked before generation, and the assistant returns concentration, draw volume, and a reconstitution workflow tailored to KPV MAX.
Inputs are inside normal laboratory ranges: 5 mg/mL, draw 0.05 mL (5 U), ~40 aliquots per vial · aliquot = 250 mcg.
Draw volume in every unit: 0.05 mL · 50 µL · 5 U.
Target aliquot: 250 mcg · 0.25 mg · 0.0003 g.
Dosing schedule generator
Choose a cadence and a time window to lay out a day-by-day plan with per-day and cumulative totals, draw volumes, and vials required. Planning aid for laboratory record-keeping only.
1 aliquot every day
1 – 180 days
- Aliquots
- 14
- Total mass (mcg)
- 3,500
- Total draw
- 0.7 mL
- Vials required
- 0.35
14 active / 0 rest days
250 mcg per aliquot
0.05 mL per aliquot
stock 1 · 1 vial ≈ 14 days
| Day | Date | Times | Daily (mcg) | Draw (mL) | Cumulative (mcg) | Vials |
|---|---|---|---|---|---|---|
| 1 | Aug 28, 2026 Fri | 08:00 | 250 | 0.05 | 250 | 0.03 |
| 2 | Aug 29, 2026 Sat | 08:00 | 250 | 0.05 | 500 | 0.05 |
| 3 | Aug 30, 2026 Sun | 08:00 | 250 | 0.05 | 750 | 0.08 |
| 4 | Aug 31, 2026 Mon | 08:00 | 250 | 0.05 | 1,000 | 0.1 |
| 5 | Sep 1, 2026 Tue | 08:00 | 250 | 0.05 | 1,250 | 0.13 |
| 6 | Sep 2, 2026 Wed | 08:00 | 250 | 0.05 | 1,500 | 0.15 |
| 7 | Sep 3, 2026 Thu | 08:00 | 250 | 0.05 | 1,750 | 0.18 |
| 8 | Sep 4, 2026 Fri | 08:00 | 250 | 0.05 | 2,000 | 0.2 |
| 9 | Sep 5, 2026 Sat | 08:00 | 250 | 0.05 | 2,250 | 0.23 |
| 10 | Sep 6, 2026 Sun | 08:00 | 250 | 0.05 | 2,500 | 0.25 |
| 11 | Sep 7, 2026 Mon | 08:00 | 250 | 0.05 | 2,750 | 0.28 |
| 12 | Sep 8, 2026 Tue | 08:00 | 250 | 0.05 | 3,000 | 0.3 |
| 13 | Sep 9, 2026 Wed | 08:00 | 250 | 0.05 | 3,250 | 0.33 |
| 14 | Sep 10, 2026 Thu | 08:00 | 250 | 0.05 | 3,500 | 0.35 |
| Totals | 3,500 | 0.7 | 3,500 | 0.35 | ||
Planning aid · Research Use Only · not for human or veterinary administration
Protocol history
Saved protocols for this compound will appear here. Every generated dosing & reconstitution result is stored locally on this device so you can revisit or reprint an earlier version.
Saved calculations across every compound live on the calculation history page.
Literature
Research Citations
Curated entry points into the peer-reviewed record for this compound. Links open indexed searches at the U.S. National Library of Medicine so you can verify the current literature yourself rather than relying on a static citation list.
- KPV tripeptide gut barrier researchPubMed literature index
- alpha-MSH C-terminal fragment NF-kBPubMed literature index
- palmitoylethanolamide PEA mast cell modulationPubMed literature index
- hyaluronic acid mucosal hydrationPubMed literature index
- KPV MAX chemical recordPubChem, NIH National Library of Medicine
Compliance
KPV MAX is supplied strictly as a laboratory reference material. It is not a drug, supplement, food, or cosmetic, and it is not for therapeutic or diagnostic use, human consumption, or veterinary use. Purchasers are responsible for handling the material in accordance with their institutional and jurisdictional requirements.
← Back to catalogCustomer reviews
Verified Feedback
Rating summary
Loading reviews…
Write a review
Shipping & Returns
Delivery & Refund Policy
Related Peptides
Similar by category, dosage, or research focus.
